GlassScriptPhysician profile
Jody N Hefner
NPI 1679629869
$1,265.29
in general payments reported to CMS, 2019-2025
20 companies · $35.75 in 2025
The $35.75 reported for 2025 was less than what a typical Pediatric Gastroenterology provider received nationally (typical 2025 total: $195).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $94.92 · 2020: $61.67 · 2021: $256 · 2022: $276 · 2023: $416 · 2024: $124 · 2025: $35.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $554 · Education: $22.16.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $554.23 |
| Education | $22.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $392.92 | 2022-2024 | Dupixent |
| Dexcom, INC. | $263.19 | 2021-2024 | Dexcom G6 Transmitter |
| Novo Nordisk INC | $92.35 | 2019-2021 | |
| Genzyme Corporation | $68.67 | 2023-2025 | |
| Abbott Laboratories | $67.19 | 2020-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $46.46 | 2024-2025 | Eohilia |
| Medtronic Minimed, INC. | $41.67 | 2019-2020 | |
| Eisai INC. | $39.16 | 2021-2022 | |
| Medtronic, INC. | $31.81 | 2021-2023 | Minimed 780g |
| Biomarin Pharmaceutical INC. | $28.05 | 2022-2023 | Voxzogo 1.2mg |
| Jazz Pharmaceuticals INC. | $26.42 | 2022 | |
| Mirum Pharmaceuticals, INC. | $24.90 | 2022 | |
| Xeris Pharmaceuticals, INC. | $23.59 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $19.40 | 2019 | |
| Abbvie INC. | $18.97 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Qol Medical, LLC | $18.13 | 2024 | Sucraid |
| Tandem Diabetes Care, INC. | $16.81 | 2019 | |
| Azurity Pharmaceuticals, INC. | $16.44 | 2023 | Triptodur |
| Insulet Corporation | $14.94 | 2021 | |
| Eton Pharmaceuticals, INC. | $14.22 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jody Hefner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.